CCCC Jul 2024 7.500 put

OPR - OPR Delayed price. Currency in USD

Add to watchlist

2.7000

0.0000

(0.00%)

As of 02:15PM EDT. Market open.

Loading interactive chart…

Simply Wall St.
It Looks Like C4 Therapeutics, Inc.'s (NASDAQ:CCCC) CEO May Expect Their Salary To Be Put Under The Microscope
Key Insights C4 Therapeutics will host its Annual General Meeting on 20th of June Salary of US$639.0k is part of CEO...
GlobeNewswire
C4 Therapeutics Appoints Ron Cooper as Chairman of the Board of Directors
Cooper Brings Decades of Global Pharmaceutical and Biotechnology Leadership Experience Bruce Downey Remains a Member of the Board of Directors and Chair of the Organization, Leadership and Compensation Committee Transition Further Highlights Commitment to Strategically Transform the Board to Lead C4T into Next Phase of Growth WATERTOWN, Mass., June 10, 2024 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted p
Simply Wall St.
We Think C4 Therapeutics (NASDAQ:CCCC) Can Afford To Drive Business Growth
Just because a business does not make any money, does not mean that the stock will go down. For example, although...